A groundbreaking advancement in neural engineering could soon provide scientists with an unprecedented level of precision when studying the human brain, while laying the groundwork for next-generation treatments for complex neurological conditions such as epilepsy. Researchers from an international collaboration—including the Technical University of Denmark (DTU), the University of Copenhagen, and University College London—have successfully developed a long, needle-thin brain electrode that integrates multiple microscopic channels into a single, flexible structure.
Known as the microfluidic Axialtrode, or mAxialtrode, the newly invented device is designed to offer multiple functional points along its entire length. This innovative configuration allows researchers to simultaneously record neural activity, deliver precise doses of medication, and apply targeted light or electrical stimulation to various locations across different regions of the brain. The detailed findings of this technological leap have been published in the peer-reviewed scientific journal Advanced Science.
A Multifunction Tool for Brain Research
At its current stage of development, the technology is primarily intended to serve as an advanced research tool for neuroscientists. Investigators will be able to utilize the mAxialtrode to closely examine how electrical signals travel through the complex layers of the brain during critical cognitive and pathological processes, including memory formation, decision-making, and the onset of seizures associated with epilepsy.
Looking further into the future, the research team envisions significant therapeutic applications for the device. One promising clinical avenue involves utilizing the mAxialtrode to deliver targeted pharmaceutical treatments directly to precise microscopic locations within the brain, while simultaneously applying localized electrical or light stimulation to modify abnormal neural circuit activity.
Postdoc Kunyang Sui, who conceptualized and developed the mAxialtrode alongside Associate Professor Christos Markos, emphasizes that the primary advantage of the new design lies in its ability to combine several distinct capabilities within a single implant. This consolidation allows researchers to perform considerably more intricate and precise experiments while drastically reducing the need to insert multiple invasive devices into delicate brain tissue.
"Most current brain implants are based on hard materials such as silicon, which can irritate the brain and trigger inflammatory reactions in the tissue," Sui explains, highlighting the biological incompatibility that has long plagued neural interfaces. "The new implant differs in that it is made of soft, plastic-like optical fibers and has a specially angled tip that makes it smaller and reduces the damage caused when it is placed in the brain."
Despite the immense potential demonstrated in early trials, Sui cautions that the technology remains a significant distance away from routine clinical use in human patients. Extensive biocompatibility testing, further technical refinement, and rigorous regulatory approvals will all be required before the mAxialtrode can be safely and effectively transitioned into clinical practice.
Moving Beyond Conventional Optical Fibers
To understand the significance of the mAxialtrode, it is helpful to look at the limitations of the technology currently dominating neuroscience laboratories. Brain researchers frequently rely on flat-ended optical fibers to conduct experiments. These thin threads, which are typically manufactured from specialized glass or plastic, are capable of carrying pulses of light deep into regional structures of the brain. They are the foundational hardware for optogenetics, a revolutionary technique that allows scientists to genetically target and activate specific nerve cells using light.
However, conventional fibers suffer from a fundamental physical limitation. They generally interact with surrounding brain tissue exclusively at their terminal end. This means that researchers using traditional fibers can typically stimulate or monitor only one isolated location at a time.
The outermost terminal of the fiber is known as the distal tip, or the functional "nose" of the implant. Light is emitted, and direct contact with the surrounding brain tissue occurs, solely at this precise point. Consequently, scientists are frequently restricted to measuring or stimulating a single brain layer during a given phase of an experiment. This restriction poses a major challenge because many vital brain functions, as well as pathological states, depend heavily on complex, dynamic communication occurring simultaneously across several distinct layers and deeper anatomical structures.
How the New Brain Implant Works
The manufacturing process of the needle-thin mAxialtrode is a marvel of materials science. The device begins as a substantially larger polymer rod. Researchers heat this specialized material and draw it down into an extremely fine, elongated fiber. The process bears a conceptual similarity to producing a remarkably delicate strand of spun sugar, though it requires vastly greater mechanical and thermal precision to ensure the internal structures remain intact.
Running directly through the center of the finished fiber is a specialized light-conducting core. Surrounding this central core are eight microscopic channels designed specifically to transport liquids. These same microfluidic channels also have the capacity to house extremely thin metal wires, which are utilized to measure electrical activity within the brain tissue.
The resulting fiber measures less than half a millimeter across in total diameter. In addition to its microscopic scale, the implant is engineered to be highly flexible. This flexibility allows the device to physically shift and move in tandem with the natural micro-movements of brain tissue, rather than cutting rigidly through it. This stark contrast in mechanical stiffness is critically important for long-term integration, as harder, more rigid implants are well-documented to trigger chronic inflammatory responses when left resident in the brain over extended periods.
Tested in Living Mice
To validate the real-world utility of their invention, the research team moved beyond theoretical designs and laboratory benches, testing the system "in vivo" within living mice. During these trials, the microfluidic electrode was surgically implanted into the brains of the animal subjects. The external ends of the implant were then connected to specialized light sources, sensitive recording equipment, and miniature medical pumps capable of precisely metering fluid delivery.
The experimental results confirmed that the device could successfully stimulate nerve cells using both blue and red light frequencies. Simultaneously, the researchers were able to record accurate electrical activity from both shallow and deep anatomical regions of the brain, including the cerebral cortex and the hippocampus.
Furthermore, the team demonstrated the capability to inject different chemical substances at separate, controlled tissue depths, with fluid delivery points spaced nearly three millimeters apart along the length of the single implant. Remarkably, all of these simultaneous measurements and targeted forms of stimulation were achieved using a single lightweight fiber that the test mice were able to carry freely without displaying any obvious signs of behavioral distress or discomfort.
Potential Applications in Epilepsy and Neuroscience
The successful in vivo experiments and comprehensive neurophysiological validation were carried out through a close partnership with Associate Professor Rune W. Berg of the University of Copenhagen and Associate Professor Rob C. Wykes from University College London. Their respective contributions provided the team with essential expertise in analyzing complex neural circuits and developing robust experimental models highly relevant to human neurological disorders, particularly epilepsy.
Building on the success of these preclinical trials, the research team is currently working to secure patents for the novel technology underlying the brain electrode. At the same time, the scientists are actively exploring the necessary developmental milestones required to eventually advance the device toward human clinical trials.
